POOL vs STOK · P/E 18, rev $5.31B vs rev $36.6M
Pool Corporation (POOL) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
POOL currently screens at market cap $7.08B and trailing P/E 17.9. STOK currently screens at market cap $1.88B.
Not investment advice. Open the POOL and STOK stock pages for the full models.
Not investment advice.